Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia

Recombinant human activated protein C (APC), which has both anticoagulant and anti-inflammatory properties, improves survival of patients with severe sepsis. This beneficial effect is especially apparent in patients with pneumococcal pneumonia. Earlier treatment with APC in sepsis has been associate...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Thrombosis and haemostasis Ročník 106; číslo 6; s. 1189
Hlavní autori:	Schouten, Marcel, van 't Veer, Cornelis, Roelofs, Joris J T H, Gerlitz, Bruce, Grinnell, Brian W, Levi, Marcel, van der Poll, Tom
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Germany 01.12.2011
Predmet:	Animals Anti-Inflammatory Agents - administration & dosage Antithrombin III - metabolism Biomarkers - metabolism Blood Coagulation - drug effects Cytokines - metabolism Disease Models, Animal Down-Regulation Fibrin Fibrinogen Degradation Products - metabolism Humans Lung - drug effects Lung - metabolism Lung - pathology Male Mice Mice, Inbred C57BL Peptide Hydrolases - metabolism Pneumonia, Pneumococcal - blood Pneumonia, Pneumococcal - immunology Protein C - administration & dosage Recombinant Proteins - administration & dosage Streptococcus pneumoniae - growth & development Streptococcus pneumoniae - immunology Streptococcus pneumoniae - pathogenicity
ISSN:	0340-6245, 2567-689X, 2567-689X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!